Protalix BioTherapeutics (PLX) Return on Sales (2010 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly Return on Sales of 0.01% for Q1 2026, up 1.0% year-over-year from 0.01% in Q1 2025, and up 238.67% quarter-over-quarter from 0.0% in Q4 2025.
Protalix BioTherapeutics (PLX) Return on Sales (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics' Return on Sales history runs 17 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Sales rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.01%, up from 0.0% in the prior quarter.
- The five-year high for Return on Sales was 0.01% in Q4 2024, with the low at 0.02% in Q4 2023.
- The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.0%.
- The sharpest annual moves came in 2023 and 2024: Return on Sales declined 2 bps in 2023, then grew 3 bps in 2024.
- Protalix BioTherapeutics' Return on Sales stood at 0.0% in 2022, then plunged by 415 bps to 0.02% in 2023, then soared by 131 bps to 0.01% in 2024, then slumped by 166 bps to 0.0% in 2025, then soared by 239 bps to 0.01% in 2026.
- Business Quant data shows PLX's Return on Sales at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Protalix BioTherapeutics | 189.97 Mn | 149.31 Mn | 12.13 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |